erdafitinib
janssen
[]
the #oncoalerttoptweet day2 of #gi23 tweet #erdafitinib in patients with #cholangiocarcinoma and #fgfr alterations orr 60% dcr 100% median pfs 8.4 months best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨